Jackson, Brittany A.,Huang, Glenn,Burke, James,Lin, Ton,Wheeler, Larry A.,Hughes, Patrick M.,Donn, Rosy S.,Zhang, Kai-Ming
申请号：
AU2013200321
公开号：
AU2013200321A1
申请日:
2013.01.22
申请国别(地区):
AU
年份:
2013
代理人:
摘要：
#$%^&*AU2013200321A120130207.pdf#####C:\NRPortbl\DCC\FMT\4865366 _.DOC-I6/01/2013 ABSTRACT Biocompatible intraocular implants include an alpha-2 adrenergic receptor agonist and a polymer associated with the alpha-2 adrenergic receptor agonist to facilitate release of the alpha-2 adrenergic receptor agonist into an eye for an extended period of time. The alpha-2 adrenergic receptor agonist may be associated with a biodegradable polymer matrix, such as a matrix of a two biodegradable polymers. The implants can be placed in an eye to treat one or more ocular conditions, such as an ocular vasculopathy or glaucoma, among others or to improve vision in a normal eye.
